Editorial review: An update on central sensitivity syndromes and the issues of nosology and psychobiology

Current Rheumatology Reviews

Volumn 11, Issue 2, 2015, Pages 70-85

  Yunus, Muhammad B ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Central sensitivity syndromes; Central sensitization; Chronic pain; Fibromyalgia; Functional syndromes; Nosology; Overlapping syndromes; Peripheral pathology; Psychology; Small fiber neuropathy; Somatization

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTERIOR CINGULATE; BURNING MOUTH SYNDROME; CANDIDIASIS; CENTRAL NERVOUS SYSTEM SENSITIZATION; CHRONIC COUGH; COMPLEX REGIONAL PAIN SYNDROME; DISEASE CLASSIFICATION; DYSPEPSIA; EDITORIAL; FIBROMYALGIA; GLIA CELL; HEADACHE; HUMAN; IRRITABLE COLON; LOW BACK PAIN; MIGRAINE; NEUROIMAGING; OSTEOARTHRITIS; PATIENT CARE; PELVIS PAIN SYNDROME; PERIAQUEDUCTAL GRAY MATTER; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PSYCHOBIOLOGY; RHEUMATOID ARTHRITIS; SLEEP DEPRIVATION; V; VULVODYNIA; ANALGESIA; ANIMAL; CHRONIC PAIN; DISEASE MODEL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; CENTRAL NERVOUS SYSTEM SENSITIZATION; CHRONIC PAIN; DISEASE MODELS, ANIMAL; HUMANS; NEUROIMAGING; PAIN MANAGEMENT;

EID: 84937133193     PISSN: 15733971     EISSN: 18756360     Source Type: Journal    
DOI: 10.2174/157339711102150702112236     Document Type: Editorial

References (200)

1. Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007; 36: 339-356.
2. Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education: Relieving Pain in America, A Blueprint for Transforming Prevention, Care, Education and Research. The National Academies Press, 2011. http: //books.nap.edu/openbook.php?record_id=13172&page=1.
3. Gracely RH, Schweinhardt P. Programmed symptoms: disparate effects united by purpose. Curr Rheumatol Rev, in press
4. Staud R. Cytokine and immune system abnormalities in fibromyalgia and other central sensitivity syndromes. Curr Rheumatol Rev
5. Jones G. Psychosocial vulnerability and early life adversity as risk factors for central sensitivity syndromes. Curr Rheumtol Rev, in press
6. Nijs J, Meeus M, Versijpt J, et al. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opinion Therapeutic Targets 2015; 19: 565-76.
7. Walitt B, Ceko M, Gracely J, Gracely RH. Neuroimaging of central sensitivity syndromes: key insights from the scientific literature. Curr Rheumatol Rev, in press
8. Woolf CJ, Thompson SW, King AE. Prolonged primary afferent induced alterations in dorsal Horn neurones, an intracellular analysis in vivo and in vitro. J Physiol (Paris) 1988-89; 83: 255- 66.
9. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011; 152: S2-S15.
10. Kuner R. Central mechanisms of pathological pain. Nature Medicine 2010; 16: 1258-66.
11. Ru-Rong Ji, Temugin B, Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain 2013; 154: S10-S28.
12. Jaspersen A, Amris K, Graven-Nielsen T, et al. Assessment of pressure-pain thresholds and central sensitization of pain in lateral epicondylalgia. Pain Med 2013; 14: 297-304.
13. van Wilgen CP, Konopka KH, Keizer D, et al. Do patients with chronic patellar tendinopathy have an altered somatosensory profile? A quantitative sensory testing (QST) study. Scand J Med Sci Sports 2013; 23: 149-55.
14. Zanette G, Cacciatori C, Tamburin S. Central sensitization in carpal tunnel syndrome with extraterritorial spread of sensory symptoms. Pain 2010; 148: 227-36.
15. Yunus MB. The prevalence of fibromyalgia in other chronic pain conditions. Pain Research & Treatment 2012; article ID 584573.
16. Phillips K, Clauw DJ: future directions. Central pain mechanisms in the rheumatic diseases. Arthritis Rheum 2013; 65: 291-302.
17. Defazio G, Tinazzi M, Beradelli A. How pain arises in Parkinson's disease? Eur J Neurol 2013; 20: 1517-23.
18. Fernandez-de-las-Penas C, Ortega-Santiago R, Oritz-Gutierrez R, et al. Widespread pressure pain hypersensitivity in patients with multiple sclerosis with and without pain as sign of central sensitization. Clin J Pain 2015; 31: 66-72.
19. Suzuki R, Dickerson A. Spinal and supraspinal contributions to central sensitization in peripheral neuropathy. Neurosignals 2005; 14: 175-81.
20. Falk S, Dickerson AH. Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncology 2014; 32: 1647-54.
21. Skou ST, Graven-Nielsen T, Rasmussen S, et al. Widespread sensitization in patients with chronic pain after revision total knee arthroplasty. Pain 2013; 154: 1588-94.
22. Aranda-Villalobos P, Fernandez-de-las-Penas C, Navarro- Espigares JL, et al. Normalization of widespread pressure pain hypersensitivity after total hip replacement in patients with hip osteoarthritis is associated with clinical and functional improvements. Arthritis Rheum 2013; 65: 1262-70.
23. Hansson P. Translational aspects of central sensitization induced by primary afferent activity: what it is and what it is not. Pain 2014; 155: 1932-34.
24. Brosschot JF. Cognitive-emotional sensitization and somatic health complaints. Scand J Psychol 2002; 43: 113-21.
25. Yunus MB. Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Bailliere's Clin Rheumatol 1994; 8: 811-37.
26. Woolf CJ. What to call the amplification of nociceptive signals in the central nervous system that contribute to widespread pain? Pain 2014; 155: 1911-12.
27. Woolf CJ, Chong MS. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993; 77: 362-79.
28. Yunus MB. Central sensitivity syndromes: a unified concept for fibromyalgia and other similar maladies. JIRA 2000; 8: 27-33.
29. Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Reports 2004; 8: 369-78.
30. Osler W. Arthritis deformans (rheumatoid arthritis) in: The principles and practice of medicine. New York: D. Appleton and Company 1892, pp 282-287.
31. Arendt-Nielsen L, Yarnitsky D. Experimental and clinical application of quantitative sensory testing applied to skin, muscles and viscera. J Pain 2009; 10: 556-72.
32. Nijs J, Van Houdenhove B, Oostendorp RAB. Recognition of central sensitization in patients with musculoskeletal pain: application of pain neurophysiology in manual therapy practice. Manual Ther 2010; 15: 135-41.
33. Mandl L. Treating the pain of osteoarthritis-where do we go from here? J Rheumatol 2011; 38: 1535-37.
34. Staud R, Robinson ME, Vierck CJ, et al. Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain 2003; 105: 215-22.
35. Staud R, Weyl EE, Price DD, et al. Mechanical and heat hyperalgesia highly predict clinical pain intensity in patients with chronic musculoskeletal pain syndromes. J Pain 2012; 13: 725- 35.
36. Schuh-Hofer S, Wodarski R, Pfau DB, et al. One night of total sleep deprivation promotes a state of generalized hyperalgesia: a surrogate pain model to study the relationship of insomnia and pain. Pain 2013; 154: 1613-21.
37. Agargun MY, Takeoglu I, Gunes A, et al. Sleep quality and pain threshold in patients with Fibromyalgia. Comprehen Psychiat 1999; 40: 226-28.
38. de Tommaso M, Delussi M, Vecchio E, et al. Sleep features and central sensitization symptoms in primary headache patients. J Headache Pain 2014; 15: 64. Doi 10.1186/1
39. Lee DH, Lee KJ, Choi KI, et al. Brain alterations and neurocognitive dysfunction in patients with complex regional pain syndrome. J Pain 2015; 16:580-6.
40. Bushnell MC, Ceko M, Low LA. Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci 2013; 14: 502-11.
41. Geisser ME, Donnell CS, Petzke F, et al. Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Psychosomatics 2008; 49: 235-42.
42. Meeus M, Nijs J, Huybrechts S, et al. Evidence for generalized hyperalgesia in chronic fatigue syndrome: a case control study. Clin Rheumatol 2010; 29: 393-98.
43. Staud R, Mokthec M, Price DD, et al. Evidence for sensitized fatigue pathways in patients with chronic fatigue syndrome. Pain 2015; 156: 750-59.
44. Winger A, Kvarstein G, Wyller VB, et al. Pain and pressure pain thresholds in adolescents with chronic fatigue syndrome and healthy controls: a cross-sectional study. BMJ Open 2014; 4: e005920.
45. Lidow MS. Long-term effects of neonatal pain on nociceptive systems. Pain 2002; 377-83.
46. Rollman GB, Abdel-Shaheed J, Gillespie JM, et al. Does past pain influence current pain: biological and psychosocial model of sex differences. Eur J Pain 2004; 8: 427-433.
47. Staud R, Nagel S, Robinson ME, et al. Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double- blind, placebo-controlled study. Pain 2009; 145: 96-104.
48. Yarnitsky D. Role of endogenous pain modulation in chronic pain mechanisms and treatment. Pain 2015; 156: S24-S31.
49. Staud R, Robinson ME, Price DD. Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain 2007; 8: 893- 901.
50. Sarlani E, Grace EG, Reynolds MA, et al. Evidence for upregulated central nociceptive processing in patients with masticatory myofascial pain. J Orofacial Pain 2004; 18: 41-55.
51. Julien N, Goffaux P, Arsenault P, et al. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005; 114: 295-302.
52. King CD, Wong F, Currie T, et al. Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain 2009; 143: 172- 78.
53. Ablin JN, Buskila D. Predicting fibromyalgia, a narrative review: are we better than fools and children? Eur J Pain 2014; 18: 1060- 66.
54. Seltzer Z. Nothing in pain makes sense except in the light of genetics. Pain 2014; 155: 841-42.
55. Mobil JS. Pain genetics: past, present and future. Trends Genet 2012; 28: 258-66.
56. Young EE, Costigan M, Herbert TA, et al. Heritability of nociception 1V: Neuropathic pain assays are genetically distinct across methods of peripheral nerve injury. Pain 2014; 155: 868-80.
57. Descalzi G, Ikegami D, Ushijima T, et al. Epigenetics mechanisms of chronic pain. Trends Neuroscienci 2015; 38: 237-46.
58. Diatchenko L, Slade GD, Nackley AG, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005; 14: 135-43.
59. Diatchenko L, Slade GD, Bair E, et al. Pain sensitivity and autonomic factors associated with development of TMD: the OPPERA prospective cohort study. J Pain 2013; 14 (12 suppl): T 63- 74.
60. Weissman-Fogel I, Granovsky Y, Crispel Y, et al. Enhanced presurgical pain temporal summation response predicts postthoracotomy pain intensity during the acute postoperative phase. J Pain 2009; 10: 628-36.
61. Lavand'homme P, Roelants F. Effect of a low dose of ketamine on postoperative pain after elective Caesarian delivery according to the presence of a preoperative temporal summation. SOAP Abstract, 2009. A-258.
62. Yarnitsky D, Granot M, Nahman-Averbuch H, et al. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain 2012; 153: 1193-98.
63. Nijs J, Malfliet A, Ickmans K, et al. Treatment of central sensitization in patients with 'unexplained' chronic pain: an update. Expert Opin Pharmacother 2014; 15: 1671-83.
64. Bouwense SA, Gravensen C, Drewes AM, et al. Effects of pregabalin on central sensitization in patients with chronic pancreatitis in a randomized controlled trial. PLoS One 2012; 8: e42096.
65. Olesen SS, Bouwense SA, Wilder-Smith OH, et al. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized, controlled trial. Gastroenterology. 2011; 141: 536-43.
66. Scott CEH, Howie CR, MacDonald D, et al. Predicting dissatisfaction following total knee replacement: A prospective study of 1217 patients. J Bone Joint Surg Br 2010; 92: 1253-58.
67. Lundblad H, Kreicbergs A, Jansson KA. Prediction of persistent pain after total knee replacement for osteoarthritis. J Bone Joint Surg Br 2008; 90: 166-71.
68. Louw A, Diener I, Butler DS, et al. The effect of neuroscience education on pain, disability, anxiety and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil 2011; 92: 2041-56.
69. Ablin JN, Buskila D. Fibromyalgia syndrome-novel therapeutic targets. Maturitas 2013; 75: 335-40.
70. Loo L, Wright BD, Zylka MJ. Lipid kinases as therapeutic targets for chronic pain. Pain 2015; 156: S2-S10.
71. He W, Liu X, Zhang Y, et al. Generalized hyperalgesia in women with endometriosis and its resolution following a successful surgery. Reprod Sci 2010; 17: 1099-111.
72. Cagnie B, Dewitte V, Barbe T, et al. Physiologic effects of dry needling. Curr Pain Headache Rep 2013; 17: 348.
73. Lumley MA, Cohen JL, Borszcz GS, et al. Pain and emotion: a biopsychosocial review of recent research. J Clin Psychol 2011; 67: 942-68.
74. Fernandez-Perez AM, Villaverde-Guitierrez C, Mora-Sanchez A, et al. Muscle trigger points, pressure pain threshold, and cervical range of motion in patients with high level of disability related to acute whiplash injury. J Orthop Sports Phys Ther 2012; 42: 634-41.
75. Stubhaug A, Breivik H, Eide PK, et al. Mapping of punctate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anesthesiol Scand 1997; 41: 1124-32.
76. Vadivelu N, Mitra S, Schermer E, et al. Preventive analgesia for postoperative pain control: a broader concept. Local Reg Anesth 2014; 7: 17-22.
77. Schelereth T, Heiland A, Breimhorst M, et al. Association between pain, central sensitization and anxiety in postherpetic neuralgia. Eur J Pain 2015; 19: 193-201.
78. Rea T, Russo J, Katon W, et al. A prospective study of tender points and fibromyalgia during and after an acute viral infection. Arch Int Med 1999; 159: 865-70.
79. Buskila D, Shnaider A, Neaumann L, et al. Fibromyalgia in hepatitis C virus infection: another infectious disease relationship. Arch Int Med 1997; 157: 2497-2500.
80. Cassisi G, Sargi-Puttini P, Cazzola M. Chronic widespread pain and fibromyalgia: could there be some relationships with infections and vaccinations? Clin Exp Rheumatol 2011; 29: S118-S126.
81. Simms RW, Zerbini CA, Frerrante N, et al. Fibromyalgia syndrome in patients with immunodeficiency virus: The Boston City Hospital Clinical AIDS Team. Am J Med 1992; 92: 368-74.
82. Batheja S, Nields J, Landa A, et al. Post-treatment Lyme syndrome and central sensitization. J Neuropsychiaty Clin Neurosci 2013; 25: 176-86.
83. Rosen JM, Klumpp DJ. Mechanism of pain from urinary tract infection. International J Urology 2014; 21(suppl 1): 26-32.
84. Foster DC, Falsetta ML, Woeller CF, et al. Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women. Pain 2015; 156: 386-96.
85. Farmer M. What is special about the vulvar vestibule? Pain 2015; 156: 359-60.
86. Lee M, Silverman SM, Hansen H, et al. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011; 14: 145-61.
87. Boomerhsine C. Fibromyalgia: prototypical central sensitivity syndrome. Curr Rheumatol Rev, in press
88. Nakai H, Kawamura Y, Sugata K, et al. Host factors associated with the kinetics of Epstein-Barr virus DNA load in patients with primary Epstein-Barr virus infection. Microbiol Immunol 2012; 56: 93-98.
89. Arya LA, Northington GM, Asfaw T, et al. Evidence of bladder oversensitivity in the absence of an infection in premenopausal women with a history of recurrent urinary tract infections. BJU Int 2012; 110: 247-51.
90. Jennings EM, Okine BN, Roche M, et al. Stress-induced hyperalgesia. Prog Neurobiol 2014; 121: 1-18.
91. Rivat C, Becker C, Blugeot A, et al. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia. Pain 2010; 150: 358-68.
92. Moeller-Bertram T, Strigo IA, Simmons AN, et al. Evidence for actue central sensitization to prolonged experimental pain in posttraumatic stress disorder. Pain Medicine 2014; 15: 762- 71.
93. Berger JV, Knaepin L, Janssen SP, et al. Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches. Brain Res Rev 2011; 671: 282-310.
94. Kundermann B, Krieg JC, Schreiber W, et al. The effect of sleep deprivation on pain. Pain Res Manage 2004; 9: 25-32.
95. McGreevy K, Bottros MM, Raja SN. Preventing chronic pain following acute pain: risk factors, preventive strategies, and their efficacy. Eur J Pain Suppl 2011; 5: 365-72.
96. Nijs J, Torres-Cueco R, van Wilgen P, et al. Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. Pain Physician 2014; 17: 447- 57.
97. Krumova EK, Geber C, Westermann A, et al. Neuropathic pain: is quantitative sensory testing helpful? Curr Diab Rep 2012; 12: 393- 402.
98. Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 2008; 37: 339-52.
99. Ablin K, Clauw DJ. From fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: Evolution of a clinical construct. Rheum Dis Clin N Am 2009; 35: 233-51.
100. Van Houdenhove B. Central sensitivity syndromes: stress system failure may explain the whole picture (letter). Semin Arthritis Rheum 2009; 39: 218-9 (author reply pp 220-21).
101. Kindler LL, Bennett RM, Jones KD. Central sensitivity syndromes: Mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders. Pain Manage Nursing 2011; 12: 15-24.
102. Ang DC, Chakr R, France CR, et al. Association of nociceptive responsivity with clinical pain and the moderating effect of depression. J Pain 2011; 12: 384-89.
103. Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep 2011; 13: 513-20.
104. Mayer T, Neblett R, Cohen H, et al. The development and psychometric validation of the central sensitization inventory. Pain Practice 2012; 12: 276-85.
105. Neblett R, Hartzell MM, Cohen H, et al. Ability of the Central Sensitization Inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. Clin J Pain 2015; 31: 323-32.
106. Deitos A, Dussan-Sarria JA, de Souza A, et al. Clinical value of serum neuroplasticity mediators in identifying the central sensitivity syndrome in patients with chronic pain without structural pathology. Clin J Pain 2014 December 30 [Epub ahead of print].
107. Hoffman D. Central and peripheral generators in women with chronic pelvic pain: patient centered assessment and treatment. Curr Rheumatol Rev, in press
108. Potts JM. Male pelvic pain: beyond urology and chronic prostatitis. Curr Rheumatol Rev, in Press
109. Fernandez-de-las-Penas C, Svensson P. Myofascial temporomandibular disorders. Current Rheumatol Rev, in press
110. Adams LM, Turk DC. Psychosocial factors and central sensitivity syndromes. Current Rheumatol Rev, in press
111. Williams DA. Cognitive behavioral therapy in central sensitivity syndromes. Curr Rheumatol Rev, in press
112. Cashman MD. Irritable bowel syndrome: a clinical review. Curr Rheumatol Rev, in press
113. de Tommaso M, Fernandez-de-las-Penas C. Tension type headache. Curr Rheumatol Rev, in press
114. de Tommaso M. Migraine. Curr Rheumatol Rev, in press
115. Pratt DP. Restless legs syndrome/ Willis-Ekbom disease and periodic limb movements: A comprehensive review of epidemiology, pathophysiology, and treatment considerations. Curr Rheumatol Rev, in press
116. Dantoff T, Andersson L, Nordin S, Skovbjerg S, Chemical intolerance. Curr Rheumatol Rev, in press
117. Moeller-Bertram T, Keltner J, Strigo IA. Pain and post traumatic stress disorder-review of of clinical and experimental evidence. Neuropharmacology 2012; 62: 586-97.
118. Kindler L, Jones K, Perrin N, Bennett RM. Risk factors predicting the development of widespread pain from chronic back or neck pain. J Pain 2010; 11: 1320-28.
119. Littlejohn GO. Repetitive strain syndrome: an Australian experience. J Rheumatol 1986; 13: 1004-06.
120. Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 2008; 179: S61-67.
121. Yang CC, Lee JC, Kromm BG, et al. Pain sensitization in male chronic pelvic syndrome: why are symptoms so difficult to treat? J Urol 2003; 170: 823-26.
122. Stone AM, Vicenzino B, Lim EC, et al. Measures of central hyperexcitability in chronic whiplash associated disorder-a systemic review and meta- analysis. Man Ther 2013; 18: 111-7.
123. Roussel NA, Nijs J, Neeus M, et al. Central sensitization and altered central pain processing in chronic low back pain: fact or myth? Clin J Pain 2013; 29: 625-38.
124. Anand P, Aziz Q, Willert R, et al. Peripheral and central mechanisms of visceral sensitization in men. Neurogastroenterol Motil 2007; 19 (Suppl 1): 29-46.
125. Kim SE, Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil 2012; 24: 895-913.
126. Li X, Wong RK, Ho KY, et al. Visceral and somatic sensory function in functional dyspepsia. Neurogastroenterol Motil 2013; 25: 246-53.
127. Coculescu EC, Radu A, Coculescu BI. Burning mouth syndrome: a review on diagnosis and treatment. J Med Life 2014; 7: 512-15.
128. Forssell H, Jaaskelainen S, List T, et al. An update on pathophysiological mechanisms related to idiopathic oro-facial pain conditions with implications for management. J Oral Rehabil 2015; 42: 300-22.
129. Lauria G, Majorana A, Borgna M, et al. Trigiminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115: 332-37.
130. Caro XJ, Winter EF. Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications. Arthritis Rheumatol 2014; 66: 1945-54.
131. Gremeau-Richard C, Dubray C, Aublet-Cuvelier B, et al. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain 2010; 149: 27-32.
132. Rhodus NL, Fricton J, Carlson P, et al. Oral symptoms associated with fibromyalgia syndrome. J Rheumtol 2003; 30: 1841-45.
133. Corsalini M, Di Venere D, Pettini F, et al. Temporomandibular disorders in burning mouth syndrome patients: an observational study. Int J Med Sci 2013; 10: 1784-89.
134. O'Neill J, McMahon SB, Undem BJ. Chronic cough and pain: Janus faces in sensory neurobiology? Pulm Pharmacol Ther 2013; 26: 476-85.
135. Morice AH, Fontana GA, Belvisi MG, et al. ERS guidelines on the assessment of cough. Eur Respir J 2007; 29: 1256-76.
136. Ford AC, Forman D, Moayyedi P, et al. Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax 2006; 61: 975-79.
137. Adjamian P, Hall DA, Palmer AR, et al. Neuroanatomical abnormalities in chronic tinnitus in the human brain. Neurosci Biobehav Rev 2014; 45: 119-33.
138. Wolfe F, Rasker JJ, Hauser W. Hearing loss in fibromyalgia? Somatic sensory and non- sensory symptoms in patients with fibromyalgia and other rheumatic disorders. Clin Exp Rheumatol 2012; 30 (6 Suppl 74): 88-93.
139. Bayazit YA, Gursoy S, Ozer E, et al. Neurotologic manifestations of the fibromyalgia syndrome. J Neurol Sci 2002; 196: 77-80.
140. Porporatti AL, Costa YM, Stuginski-Barosa J, et al. Quantitative methods for somatosensory evaluation in atypical odontalgia. Braz Oral Res 2015; 29: 1-7.
141. Pareja JA, Cuadraodo ML, Porta-Etessam J, et al. Idiopathic ophthalmodynia and idiopathic rhinalgia: two topographic facial pain syndromes. Headache 2010; 50: 1286-95.
142. Yunus MB, Masi AT, Calabro JJ, et al. Primary fibromyalgia (Fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981; 11: 151-71.
143. Borchers AT, Gershwin ME. Complex regional pain syndrome: a comprehensive and critical review. Autoimmunity Reviews 2014; 13: 242-65.
144. Birklein F, Schlereth T. Complex regional pain syndrome- significant progress in understanding. Pain 2015; 156: S94-S103.
145. Yunus MB. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J Rheumatol 1992; 19: 846-50.
146. Caro XJ, Winter EF, Dumas A. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology (Oxford) 2008; 47: 208-11.
147. Oaklander AL, Herzog ZD, Downs HM, et al. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 2013; 154: 2310-16.
148. Uceyler N, Zeller D, Kahn AK, et al. Small fiber pathology in patients with fibromyalgia syndrome. Brain 2013; 136 (Pt 6): 1857- 67.
149. Oaklander AL, Klein MM. Evidence of small fibre polyneuropathy in unexplained, juvenile- onset, widespread pain syndromes. Pediatrics 2013; 131: e1091-100.
150. Ramirez-Fernandez M, Martinez-Martinez L-A, Vargas-Guerrero A, et al. Small fiber neuropathy in women with fibromyalgia. a clinical-pathological correlation using confocal corneal biomicroscopy. Arthritis Rheum 2014; 66: S396.
151. Giannoccaro MP, Donadio V, Incensi A, et al. Small nerve fiber involvement in patients referred for fibromyalgia. Muscle Nerve 2014; 49: 757-59.
152. Salemi S, Rethage J, Wollina U, et al. Detection of interleukin 1 beta (IL-1 beta), IL-6, and tumor necrosis factor- alpha in skin of patients with fibromyalgia. J Rheumatol 2003; 30: 146-50.
153. Bachmann CG, Rolke R, Scheidt U, et al. Thermal hypoaesthesia differentiates secondary restless legs syndrome associated with small fiber neuropathy from primary restless legs syndrome. Brain 2010; 133: 65-70.
154. Uceyler N, Hauser W, Sommer C. Systematic review with metaanalysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord. 2011; 12: 245.
155. Dinan TG, Clarke G, Quigley EM, et al. Enhanced cholinergicmediated increase in the pro- inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am J Gastroenterol 2008; 103: 2570-6.
156. Schrepf A, O'Donnell M, Luo Y, et al. Inflammation and inflammatory control in interstitial cystitis/ bladder pain syndrome: associations with painful symptoms. Pain 2014; 155: 1755- 61.
157. Keay SK, Birder LA, Chai TC. Evidence for bladder urothelial pathophysiology in functional bladder disorders. Biomed Res Int 2014; 2014: 865463.
158. Nasser Y, Boeckxstaens, Wouters MM, et al. Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome. Neurogastroenterol Motil 2014; 26: 455-69.
159. Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 1096-101.
160. Wesselmann U, Bonham A, Foster D. Vulvodynia: current state of the biological science. Pain 2014; 155: 1696-1701.
161. Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest 2004; 58: 171-78.
162. Foster DC, Falsetta ML, Woeller CF, et al. Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women. Pain 2015; 156: 386-96.
163. Farmer MA. What is special about the vulvar vestibule? Pain 2015; 156: 359-60.
164. st century. Neuroscientist 2010; 16: 171- 85.
165. Napadow V, Harris RE. What has functional connectivity and chemical neuroimaging in fibromyalgia taught us about the mechanisms and management of 'centralized' pain? Arthritis Res Ther 2014; 16: 425.
166. Talbot JD, Narrett S, Evans AC, et al. Multiple representations of pain in human cerebral cortex. Science 1991; 251 (4999): 1355-58.
167. Biswal B, Yetkin FZ, Haughton VM, et al. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 1995; 34: 537-41.
168. Cagnie B, Coppieters I, Denecker S, et al. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin Arthritis Rheum 2014; 44: 68-75.
169. Napadow V, LaCount L, Park K, et al. Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum 2010; 62: 2545-55.
170. Fregni F, Potvin K, Desilva D, et al. Clinical effects and brain metabolic correlates in non- invasive cortical neuromodulation for visceral pain. Eur J Pain 2011; 15: 53-60.
171. Baliki MN, Petre B, Torbey S, et al. Corticostrial functional connectivity predicts transition to chronic back pain. Nat Neurosci 2012; 15: 1117-19.
172. Seminowicz DA, Laferriere AL, Millecamps M, et al. MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain. Neuroimage 2009; 47: 1007-14.
173. Maletic V and Raison CL. Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci 2009; 14: 5291- 5338.
174. Demartini B, Riccardi L, Parees I, et al. A positive diagnosis of functional (psychogenic) tics. Eur J Neurol 2015; 22(3): 527-e36.
175. Russell IJ, Larson A. Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis. Rheum Dis Clin North Am 2009; 35: 421-35.
176. Dretske F. Psychologial vs biological explanations of behavior. Behavior and Philosophy 2004; 32: 167-77.
177. Kohler O, Benros ME, Nordentoft M, et al. Effect of antiinflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiat 2014; 71: 1381-91.
178. Russell IJ, Fletcher EM, Michalek JE, et al. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: a double- blind, placebo-controlled study. Arthritis Rheum 1991; 34: 552-60.
179. th edition, 1994, DSM-IV, American Psychiatric Association. Washington, DC pp xxi.
180. Trief PM, Elliot DJ, Stein N, et al. Functional vs. organic pain: a meaningful distinction? J Clin Psychol 1987; 43: 219-26.
181. th anniversary edition. Philadelphia: Da Capo Press 1989, pp171.
182. Lapowski ZJ. Somatization: the concept and its application. Am J Psychiat 1988; 145: 1358-68.
183. Wolfe F, Walitt BT, Katz RS, et al. Symptoms, the nature of fibromyalgia, and Diagnostic and statistical Manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia. PLoS One 2014; 9: e88740.
184. Crombez G, Beirens K, Van Damme S, et al. The unbearable lightness of somatisation: a systemic review of the concept of somatization in empirical studies of pain. Pain 2009; 145: 31-35.
185. Herin F, Vezina M, Thaon I, et al. Predictive risk factors for regional and multisite musculoskeletal pain: a 5-year prospective study in a working population. Pain 2014; 155: 937-43.
186. McWhinney IR, Epstein RM, Freeman TR. Rethinking somatization. Ann Int Med 1997; 126: 747-50.
187. Wolfe F, Michaud K. Outcome and predictor relationships in fibromyalgia and rheumatoid arthritis: evidence concerning the continuum versus discrete disorder hypothesis. J Rheumatol 2009; 36: 831-36.
188. Giesecke T, Williams DA, Harris RE, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003; 48: 2916-22.
189. Vincent A, Hoskin TL, Whipple MO, et al. OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis. Arthritis Res Ther 2014; 16: 463.
190. Penhoat M, Saraux A, Le Goff B, et al. High pain catastrophizing scores in one-fourth of patients on biotherapy for spondylarthritis or rheumatoid arthritis. Joint Bone Spine 2014; 81: 235-239.
191. Kotsis K, Voulgari PV, Tsifetaki N, et al. Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjogren's syndrome compared to systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int 2014; 34: 1671-81.
192. Budtz-Lilly A, Pink P, Ornbol E, et al. A new questionnaire to identify bodily distress in primary care: 'The BDS checklist.' J Psychosom Res 2015; 78: 536-45.
193. Masi AT, Vincent A. A historical perspective endorsing personcentered management of fibromyalgia. Curr Rheumatol Rev in press
194. Engel GL. The clinical application of the biopsychosocial model. Am J Psychiat 1980; 137: 535-44.
195. Vissers MM, Bussmann JB, Verhaar JA, et al. Psychological factors affecting the outcome of total hip and knee arthroplasty: a systemic review. Semin Arthritis Rheum 2012; 41: 576-88.
196. Glombiewski JA, Sawyer AT, Gutermann J, et al. Psychological treatment for fibromyalgia: a meta-analysis. Pain 2010; 151: 280- 95.
197. Dixon KE, Keefe FJ, Scipio CS, et al. Psychological interventions for arthritis pain management in adults: a meta-analysis. Health Psychol 2007; 26: 241-50.
198. Gracely RH, Geisser ME, Giesecke T, et al. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 2004; 127 (pt 4): 835-43.
199. Flor H. Psychological pain intervention and neurophysiology: implications for a mechanism-based approach. American Psychologist 2014; 69: 188-96.
200. Lener MS, Iosifescu DV. In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature. Ann NY Acad Sci 2015;1344:50-65.